Replimune (REPL) Interest Expenses (2019 - 2025)
Replimune's (REPL) quarterly Interest Expenses came in at $1.5 million in Q4 2025, up 1.1% year-on-year from $1.4 million in Q4 2024, and down 1.48% quarter-over-quarter from $1.5 million in Q3 2025.
Replimune (REPL) Interest Expenses (2019 - 2025) Analysis & Trends
Replimune has disclosed Interest Expenses across 7 years of filings, most recently posting $1.5 million for Q4 2025.
- Interest Expenses for Q4 2025 came in at $1.5 million, up 1.1% year-over-year; the trailing twelve-month figure through Dec 2025 was $5.9 million (up 2.83% YoY), and the FY2025 annual result was $5.8 million, up 28.42% from the prior year.
- Interest Expenses came in at $1.5 million for Q4 2025 at Replimune, down from $1.5 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $1.5 million in Q3 2025 to a low of $1000.0 in Q1 2021.
- The 5-year median for Interest Expenses is $1.4 million (2024), against an average of $1.2 million.
- Across the five-year window, Interest Expenses soared 100.34% in 2021 and increased 1.1% in 2025, its largest moves.
- Replimune's Interest Expenses stood at $1000.0 in 2021, then soared by 94000.0% to $941000.0 in 2022, then increased by 7.55% to $1.0 million in 2023, then surged by 43.28% to $1.4 million in 2024, then grew by 1.1% to $1.5 million in 2025.
- The last three Interest Expenses figures came in at $1.5 million (Q4 2025), $1.5 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -5.58 Mn |
| 10 | Replimune | 780.01 Mn | 510.88 Mn | - | 1.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.47 Mn |
| Dec 31, 2025 | 1.47 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Sep 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Jun 30, 2025 | 1.48 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Mar 31, 2025 | 1.46 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | 1.44 Mn |
| Sep 30, 2024 | 1.44 Mn |
| Jun 30, 2024 | 1.43 Mn |
| Jun 30, 2024 | 1.43 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Mar 31, 2024 | 1.41 Mn |
| Dec 31, 2023 | 1.01 Mn |
| Dec 31, 2023 | 1.01 Mn |
| Sep 30, 2023 | 955,000.00 |
| Sep 30, 2023 | 955,000.00 |